Table 1.

AR and acupuncture point application therapies.

Author	Number and range of age		Intervention (herbal medicine and acupoints) and duration		Outcomes	Adverse events (experimental)	Jadad score
	Experimental	Control	Experimental	Control
Zhu 2010 [23]	47/5–55	44/8–50	San-Fu-Tie, for one year	Cetirizine and beclometasone dipropionate aqueous nasal spray, for ten consecutive days	Efficacy evaluation	Not mentioned	2
			Bai Jie Zi, Xi Xin, Gan Sui, Yan Hu Suo, Ban Xia
			GV14, BL20, CV17, BL12, BL13, BL23
Chen and Gu 2011 [24]	40/4–7	34/4–7	San-Fu-Tie, for two-three consecutive years	Oxymetazoline hydrochloride spray and dexamethasone, withdrawal when symptomatic relief occurs	Efficacy evaluation	Not mentioned	2
			Bai Jie Zi, Xi Xin, Ma Huang, Xin Yi, Sheng Jiang
			GV14, BL13, BL43, PC6
Lin et al. 2014 [19]	84/5–82	84/5–82	San-Fu-Tie, four times a year (dog days are four ten-day periods in 2013), for one year	Beclometasone dipropionate aqueous nasal spray, for four weeks	Efficacy evaluation, symptom rating scale	Not mentioned	4
			Bai Jie Zi, Xi Xin, Ma Huang, Gan Sui, Yan Hu Suo, Ding Xiang, Sheng Jiang
			BL13, BL20, GV14, BL23, BL12, LI4, EX-B1, ST36, EX-HN15

Bai Jie Zi, Semen Sinapis Albae; Xi Xin, Herba Asari; Gan Sui, Radix Kansui; Yan Hu Suo, Rhizoma Corydalis; Sheng Jiang, Rhizome Zingiberis Recens; Ban Xia, Rhizoma Pinelliae; Ma Huang, Herba Ephedrae; Xin Yi, Flos Magnoliae; Ding Xiang, Flos Caryophylli.

BL13, Feishu; BL43, Gaohuang; EX-HN15, Bailao; CV17, Danzhong; EX-B1, Dingchuan; GV14, Dazhui; BL20, Pishu; BL12, Fengmen; BL23, Shenshu; PC6, Neiguan; LI4, Hegu; ST36, Zusanli.

AR, allergic rhinitis; cAMP, cyclic Adenosine Monophosphate; cGMP, cyclic Guanosine Monophosphate.